Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole Nicco

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2016
OX40L blockade protects against inflammation-driven fibrosisMuriel Elhai, Jérôme Avouac, Anna Maria Hoffmann-Vold, et al.
International Immunopharmacology|June 4, 2024
IBPA a mutual prodrug of ibuprofen and acetaminophen alleviates inflammation, immune dysregulation and fibrosis in preclinical models of systemic sclerosisAnderson Rodrigues de Almeida, Francisco Jaime Bezerra Mendonça Junior, Andréa Tavares Dantas, et al.
Inflammopharmacology|July 21, 2023
PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patientsAnderson Rodrigues de Almeida, Andréa Tavares Dantas, Maria Eduarda de Oliveira Gonçalves, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2016
OX40L blockade protects against inflammation-driven fibrosisMuriel Elhai, Jérôme Avouac, Anna Maria Hoffmann-Vold, et al.
International Immunopharmacology|June 4, 2024
IBPA a mutual prodrug of ibuprofen and acetaminophen alleviates inflammation, immune dysregulation and fibrosis in preclinical models of systemic sclerosisAnderson Rodrigues de Almeida, Francisco Jaime Bezerra Mendonça Junior, Andréa Tavares Dantas, et al.
Inflammopharmacology|July 21, 2023
PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patientsAnderson Rodrigues de Almeida, Andréa Tavares Dantas, Maria Eduarda de Oliveira Gonçalves, et al.
Pageof 10